N-<2-(p-tolyl)ethyl>-2-phenylacetamide | 83304-18-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-<2-(p-tolyl)ethyl>-2-phenylacetamide
• 英文别名: N-(4-methylphenethyl)-2-phenylacetamide；N-[2-(4-methylphenyl)ethyl]-2-phenylacetamide
• CAS: 83304-18-1
• 化学式: C₁₇H₁₉NO
• 分子量: 253.344
• InChiKey: BKDXQQUDMPWHSU-UHFFFAOYSA-N

物化性质

• 熔点：
  88-89 °C(Solvent: Ethanol)
• 沸点：
  469.7±34.0 °C(Predicted)
• 密度：
  1.063±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-<2-(p-tolyl)ethyl>-2-phenylacetamide 在 甲醇 、 sodium tetrahydroborate 、 四磷十氧化物 、 磷酸 作用下， 以 二氯甲烷 为溶剂， 反应 2.08h， 生成 2-(methoxycarbonyl)-6-nitrophenyl 1-benzyl-7-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
  参考文献：
  名称：

  氨基甲酸酯活化率的提高使得能够合成四环苯并内酰胺：8-氧代berbines及其5和7元C环同系物

  摘要：

  开发了直接酰胺化芳族环系N-氨基甲酰基四氢异喹啉底物的途径。该途径使人们能够普遍获得8-氧小ber碱及其5和7元C环同系物。它克服了导致异喹啉主链破坏的不希望的串联副反应，这种副反应在我们先前报道的超酸性氨基甲酸酯活化方法下不可避免地发生。

  DOI：

  10.1039/d0ob02096f
• 作为产物：
  描述：

  对甲基苯乙胺 、 苯乙酸乙酯 以 对二甲苯 为溶剂， 反应 72.0h， 以74%的产率得到N-<2-(p-tolyl)ethyl>-2-phenylacetamide
  参考文献：
  名称：

  氨基甲酸酯活化率的提高使得能够合成四环苯并内酰胺：8-氧代berbines及其5和7元C环同系物

  摘要：

  开发了直接酰胺化芳族环系N-氨基甲酰基四氢异喹啉底物的途径。该途径使人们能够普遍获得8-氧小ber碱及其5和7元C环同系物。它克服了导致异喹啉主链破坏的不希望的串联副反应，这种副反应在我们先前报道的超酸性氨基甲酸酯活化方法下不可避免地发生。

  DOI：

  10.1039/d0ob02096f

文献信息

• Synthesis and Photo-oxygenation of Some Substituted 1-Benzyl-3,4-dihydroisoquinolines. Mechanism of Enamine Photo-oxygenation
  作者：Ned H. Martin、Charles W. Jefford

  DOI：10.1002/hlca.19820650314

  日期：1982.5.5

  Bischler-Napieralski cyclization is described. Competitive methylene blue sensitized photo-oxygenation experiments allowed the determination of relative rates of photo-oxygenation of 1-benzyl-3,4-dihydroisoquinolines, Substituents were shown to affect both the equilibrium concentration of the tautomeric enamine and the overall photo-oxygenation rate. After correcting for differences in enamine concentration, the relative

  描述了通过Bischler-Napieralski环化合成一系列取代的1-苄基-3,4-二氢异喹啉。竞争性的亚甲基蓝敏化光氧合实验可确定1-苄基-3,4-二氢异喹啉的光氧合相对速率，已证明取代基会影响互变异构烯胺的平衡浓度和总光氧合速率。在校正了烯胺浓度的差异之后，相对速率数据提供了反应机理的诊断探针，该机理涉及限速步骤中电荷的转移。
• Synthesis and Identification of Small Molecules that Potently Induce Apoptosis in Melanoma Cells through G1 Cell Cycle Arrest
  作者：Robin S. Dothager、Karson S. Putt、Brittany J. Allen、Benjamin J. Leslie、Vitaliy Nesterenko、Paul J. Hergenrother

  DOI：10.1021/ja042913p

  日期：2005.6.1

  Late-stage malignant melanoma is a cancer that is refractory to current chemotherapeutic treatments. The average survival time for patients with such a diagnosis is 6 months. In general, the vast majority of anticancer drugs operate through induction of cell cycle arrest and cell death in either the DNA synthesis (S) or mitosis (M) phase of the cell cycle. Unfortunately, the same mechanisms that melanocytes possess to protect cells from DNA damage often confer resistance to drugs that derive their toxicity from S or M phase arrest. Described herein is the synthesis of a combinatorial library of potential proapoptotic agents and the subsequent identification of a class of small molecules (triphenyl methylamides, TPMAs) that arrest the growth of melanoma cells in the G1 phase of the cell cycle. Several of these TPMAs are quite potent inducers of apoptotic death in melanoma cell lines (IC50 similar to 0.5 mu M), and importantly, some TPMAs are comparatively nontoxic to normal cells isolated from the bone marrow of healthy donors. Furthermore, the TPMAs were found to dramatically reduce the level of active nuclear factor kappa-B (NF kappa B) in the cell; NF kappa B is known to be constitutively active in melanoma, and this activity is critical for the proliferation of melanoma cells and their evasion of apoptosis. Compounds that reduce the level of NF kappa B and arrest cells in the G1 phase of the cell cycle can provide insights into the biology of melanoma and may be effective antimelanoma agents.
• MARTIN, N. H.;JEFFORD, C. W., HELV. CHIM. ACTA, 1982, 65, N 3, 762-774
  作者：MARTIN, N. H.、JEFFORD, C. W.

  DOI：——

  日期：——